Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Let's not forget that the Pandemic is still raging, it ain't going away and there's still a requirement for testing, whether the Government likes it or not. On top of this we have Monkeypox, which some experts are already suggesting should now be declared a Pandemic.
“A new study also suggests that the virus might be mutating 12 times faster than expected, and could lead to 60,000 new cases per day in the U.K. alone by the end of 2022” this is for Monkeypox, potentially that's a lot of additional testing globally, on top of COVID.
https://www.linkedin.com/in/berna-gimenez-kappeler/
Good to see that we are expanding the sales team into LATAM.
I'm pretty certain that we supply Taiwan, they'll not be buying from the Chinese. I'd agree that the Company has suggested that testing COVID testing shall dry up, however I find that hard to believe and not every nation shall simply bury their heads in the sand.
Scary stuff!
https://www.taipeitimes.com/News/front/archives/2022/07/10/2003781480
Shanghai Finds First BA.5 Sub-Variant Case as Outbreak Grows. Country’s financial hub to step up mass testing this week.
https://www.bloomberg.com/news/articles/2022-07-10/shanghai-covid-outbreak-grows-hainan-issues-stay-home-order
https://www.tiktok.com/@bertsbeess/video/7115506679130623275?_t=8Ted2lOcPt5&_r=1
Since starting my groups have undergone significant expansion and have developed analytical and clinical processes to adhere to quality and regulatory frameworks, delivering the validation of 12 products for IVD-R submission by 1st June deadline and multiple clinical Performance studies. I also sit on the R&D Executive team, Extended leadership forum (Exec -1) and work cross functionally across the organisation, delivering company needs. additionally my team works collaboratively with Business Development to deliver OEM products.
As I've said previously, reading between the lines, clearly loads going on behind the scenes here.
Agreed, although everyone I know that has COVID at present is testing.
Myself, this evening I performed the BIOSURE CE Marked antibody test, I tested positive, had a hunch that I'd had COVID at the end of May, although the antigen tests that I did at the time were negative.
Testing continues, just not at the same scale within the UK. Still plenty High Street testing shops such as DAM and Randox within Central London.
What's the production capacity for LFT? Should a large order land for 5 million a month, could NCYT fulfil and/or what's the timescale for ramping up production.
If DA and his new team are that hot when it comes to sales and marketing....surly only a matter of time before something big lands.
Also, how many employees have been buying up shares, I'd imagine that many would have invested heavily following the CEO and CFO, therefore many within the company are hurting at present, should focus their attention, how did DA put it? Laser focused I think he said back in January.
DA made it clear after his first 100 days in office that it was likely to be Q4 before new products went to market.
Also, as we are all aware, COVID ain't over. CTDA for the new LFT could arrive any day. Where did the LFT reader come from? Is that made by IT IS?
I agree that communication is poor, however I feel that there's a reason for this.
I don't think that BIO had a heads up with regards to the RNS, simply a coincidence.
Also, was the RNS that much of a surprise? NCYT gave us all a heads up at the end of April, within the Annual Results. We are all aware that testing continued to decline around the globe, plus no company announcement with regards to new contracts.
Still think that NCYT are playing their cards close to the chest, with plenty going on behind the scenes which they are unable to report upon. Today's RNS was a Trading and Strategy update, not an R&D update.
I think that a transitionary period was to be expected, it takes time to develop and launch new products.
Why did the CEO and CFO both invest at the end of Q1, both already aware of the decline in revenues and the expected escalation of the DHSC dispute?
Guillermo Raimondo is liking posts from the following Indian company upon Linkedin. Does not appear to be linked with TATA.
https://gosamplify.com/